Working within resource constraints
The personalisation of healthcare approaches often involves complex tests and interventions with uncertain outcomes. Considering resource constraints and costs ensures that personalised medicine remains accessible and affordable for patients. By understanding economic and environmental implications, healthcare systems can make evidence-based decisions about resource allocation and prioritise interventions based on a cost-effectiveness analysis that includes the impact on the environment (of big data analysis as well as the manufacture of personalised medicine). To ensure that personalised medicine approaches are available to everyone, and sustainable, it is crucial to have robust methodologies and evidence for assessing these impacts.
The CPM helps to highlight these issues.
Latest research outputs
Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.
Horton RH. et al, (2023), Journal of medical ethics
See moreDiscussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.
Horton RH. et al, (2023), Journal of medical ethics
See moreDiscussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.
Horton RH. et al, (2023), Journal of medical ethics
See more
